Sun Pharma has showcased significant advancements in dermatology at the 2026 AAD Annual Meeting, presenting 14 abstracts on various treatments.
Tag: clinical trials
Crs: Cytokine Release Syndrome () Update
Aptevo Therapeutics has reported significant clinical benefits in treating AML without CRS, while Carpenter Technology shows strong stock performance.